跳至主要内容
临床试验/JPRN-jRCT1090220256
JPRN-jRCT1090220256招募中Unknown

Effect the determination of L- carnitine replacement therapy for the maintenance hemodialysis patients with ESA resistance anemia (study of algorithms) - Effect the determination of L- carnitine replacement therapy (study of algorithms)

shogo kimura0 个研究点目标入组 35 人开始时间: 2016年7月26日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
35

研究概览

简要总结

暂无简介。

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • patients three times a week hemodialysis have received more than one year.
  • hemodialysis patients with no change over the past one month in the esa administration.
  • Patients with hb concentration of the past three months has remained at 12g/dL
  • fc is less than the normal value 40.0
  • Patients over 20 years old
  • Patient obtained a consent with respect to the present.

排除标准

  • Patients with hypersensitivity to levocarnitine (Erukaruchin R)
  • Patients with obvious factors that influence the Hb concentration, such as moderate or severe infectious diseases, malignant tumor, hemorrhage, collagen disease, chronic liver disease, low-nutrition, and blood disease
  • Less than serum ferritin value is 100ng / mL
  • MCV is less than 90fL, more 105f

研究者

发起方
shogo kimura

相似试验